Article in BJU international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 1 institution in 1 country.
Ahmet UrkmezDivision of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0001-8357-7734
John F WardDivision of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Haesun ChoiDivision of Diagnostic Imaging, Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-3565-5475
Patricia TroncosoDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Irene InguilloDivision of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Justin R GreggDivision of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-3852-8199
Muammer AltokDivision of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0002-2194-4161
Huseyin C DemirelDivision of Surgery, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Wei QiaoDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Hyunseon C KangDivision of Diagnostic Imaging, Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.ORCID 0000-0001-5313-3526
The University of Texas MD Anderson Cancer Center · US
Funding
Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Temporal learning curve of a multidisciplinary team for magnetic resonance imaging/transrectal ultrasonography fusion prostate biopsy. · full record | OpenQuestion